Overriding TKI resistance of renal cell carcinoma by combination therapy with IL-6 receptor blockadeKei Ishibashi, Yoshiyuki Kojima|Oncotarget|2017Cited by 55
Impact of Sulfatase‐2 on cancer progression and prognosis in patients with renal cell carcinomaShin Kumagai, Yoshiyuki Kojima|Cancer Science|2016Cited by 14
l-Theanine Protects Bladder Function by Suppressing Chronic Sympathetic Hyperactivity in Spontaneously Hypertensive RatKanako Matsuoka, Yoshiyuki Kojima|Metabolites|2021Cited by 11
Involvement of Mast-Cell-Tryptase- and Protease-Activated Receptor 2—Mediated Signaling and Urothelial Barrier Dysfunction with Reduced Uroplakin II Expression in Bladder Hyperactivity Induced by Chronic Bladder Ischemia in the RatHidenori Akaihata, Yoshiyuki Kojima|International Journal of Molecular Sciences|2023Cited by 7